AgeX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 131.8%.

Top 25 shareholders own 81.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
75.6%	Juvenescence Ltd.	1,889,323	US$23.8m	304%	no data
3.41%	Broadwood Capital, Inc.	85,219	US$1.1m	0%	0.08%
0.8%	The Vanguard Group, Inc.	19,953	US$251.4k	0.48%	no data
0.33%	Sigma Planning Corporation	8,144	US$102.6k	57.9%	0.01%
0.21%	Prescott General Partners LLC	5,265	US$66.3k	0%	no data
0.16%	Bridgeway Capital Management, LLC	4,116	US$51.9k	0%	no data
0.16%	Geode Capital Management, LLC	4,008	US$50.5k	0%	no data
0.14%	BlackRock, Inc.	3,534	US$44.5k	-5.79%	no data
0.13%	Steven Mintz	3,307	US$41.7k	0%	no data
0.12%	British & American Investment Trust PLC	2,912	US$36.7k	0%	0.47%
0.11%	Strategic Wealth Investment Group, LLC	2,768	US$34.9k	5.13%	0.01%
0.08%	Creative Planning, LLC	2,010	US$25.3k	-0.25%	no data
0.048%	Michael West	1,194	US$15.0k	0%	no data
0.036%	Northern Trust Global Investments	896	US$11.3k	0%	no data
0.033%	Virtu Financial LLC, Asset Management Arm	816	US$10.3k	0%	no data
0.03%	State Street Global Advisors, Inc.	762	US$9.6k	0%	no data
0.028%	Susquehanna International Group, LLP, Asset Management Arm	706	US$8.9k	2.32%	no data
0.026%	Summit X	639	US$8.1k	-39.3%	no data
0.024%	Citadel Advisors LLC	609	US$7.7k	0%	no data
0.02%	Beirne Wealth Consulting Services, LLC	511	US$6.4k	0%	no data
0.014%	LPL Financial Corporation, Asset Management Arm	349	US$4.4k	0%	no data
0.013%	Jane Street Group, LLC, Asset Management Arm	328	US$4.1k	0%	no data
0.012%	Tower Research Capital LLC	304	US$3.8k	-18.9%	no data
0.0072%	Neal Bradsher	179	US$2.3k	0%	no data
0.0034%	Arbor Point Advisors, LLC	85	US$1.1k	0%	no data